The health analytics company, Bio Conscious, has developed AI technology that proactively identifies and predicts the onset of disease states, with a current focus on diabetes and related chronic diseases. Their products and technology operate at the intersection of connected medical devices, remote monitoring, and the growing prevalence of diabetes. By providing AI-based disease management tools like the Diabits app for patients and the Endobits web-based portal for healthcare professionals, Bio Conscious enables earlier intervention and helps avoid complications, ultimately redefining how chronic conditions are treated.